No Prescription |
 |
 | ||
|
Vectavir Cream Denavir |
|
| ||
No Prescription » Prescription Drugs 16 » Vectavir Cream Denavir Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Penciclovir is an antiviral medication. Penciclovir is used topically for the treatment of recurrent cold sores. Penciclovir (pen-SYE-kloe-veer) belongs to the family of medicines called antivirals. Antivirals are used to treat infections caused by viruses. Usually they work for only one kind or group of virus infections.Topical penciclovir is used to treat the symptoms of herpes simplex virus infections around the mouth (cold sores). Although topical penciclovir will not cure herpes simplex it may help relieve the pain and discomfort and may help the sores heal faster. Buy Vectavir Cream Denavir and other Prescription Drugs 16 products online at Medstore. 3734
About Vectavir Cream Denavir: Product Type: Prescription Drugs 16 Vectavir Cream ( Denavir Generic Penciclovir ) Vectavir Cream (Denavir Generic Penciclovir) Denavir Generic Penciclovir 1% 2gm Cream Denavir Generic Penciclovir Vectavir Cream
View more Prescription Drugs 16 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
